Biotechnology US Supreme Court Declines To Hear Vanda Pharmaceuticals’ Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz – Vanda Pharma (NASDAQ:VNDA) Read more
Biotechnology Teva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: Report – Teva Pharmaceutical Indus (NYSE:TEVA) Read more
